Maharati A, Rajabloo Y, Moghbeli M
Heliyon. 2025; 11(1):e41483.
PMID: 39834411
PMC: 11743095.
DOI: 10.1016/j.heliyon.2024.e41483.
Geng Y, DeLay S, Chen X, Miska J
Int J Mol Sci. 2025; 25(24).
PMID: 39769038
PMC: 11678534.
DOI: 10.3390/ijms252413273.
Wu J, Liu Y, Zong J, Qiu M, Zhou Y, Li Y
Adv Sci (Weinh). 2024; 12(6):e2409250.
PMID: 39716891
PMC: 11809377.
DOI: 10.1002/advs.202409250.
Sflakidou E, Adhikari B, Siokatas C, Wolf E, Sarli V
ACS Pharmacol Transl Sci. 2024; 7(11):3488-3501.
PMID: 39539259
PMC: 11555526.
DOI: 10.1021/acsptsci.4c00405.
Lanng K, Lauridsen E, Jakobsen M
Nat Immunol. 2024; 25(7):1144-1157.
PMID: 38918609
DOI: 10.1038/s41590-024-01872-3.
Spindle checkpoint activation by fungal orthologs of the S. cerevisiae Mps1 kinase.
Fabritius A, Alonso A, Wood A, Sulthana S, Winey M
PLoS One. 2024; 19(3):e0301084.
PMID: 38530809
PMC: 10965065.
DOI: 10.1371/journal.pone.0301084.
TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma.
Longo L, Hughes T, McNeil-Laidley B, Cottini F, Hilinski G, Merritt E
Haematologica. 2023; 109(2):578-590.
PMID: 37496433
PMC: 10828771.
DOI: 10.3324/haematol.2023.282838.
New cyclic glycolipids from promote MCF-7 breast carcinoma cell apoptosis by cell cycle arrest and mitotic Mps1/TTK inhibition.
Badawy S, Hassan A, Elkousy R, El Wafa S, Mohammad A
RSC Adv. 2023; 13(27):18627-18638.
PMID: 37346953
PMC: 10280128.
DOI: 10.1039/d3ra01793a.
Genetic heterogeneity in p53-null leukemia increases transiently with spindle assembly checkpoint inhibition and is not rescued by p53.
Wang M, Phan S, Hayes B, Discher D
Chromosoma. 2023; 133(1):77-92.
PMID: 37256347
PMC: 10828900.
DOI: 10.1007/s00412-023-00800-y.
[Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer].
Qin X, Zhang Y, Yu H, Ma L
Zhongguo Fei Ai Za Zhi. 2023; 26(4):310-318.
PMID: 37183646
PMC: 10186262.
DOI: 10.3779/j.issn.1009-3419.2023.101.13.
Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer.
Chen H, Zhang L, Zuo M, Lou X, Liu B, Fu T
Aging (Albany NY). 2023; 15(4):1210-1227.
PMID: 36849137
PMC: 10008491.
DOI: 10.18632/aging.204564.
Adaptation to high rates of chromosomal instability and aneuploidy through multiple pathways in budding yeast.
Clarke M, Marsoner T, Adell M, Ravichandran M, Campbell C
EMBO J. 2022; 42(8):e111500.
PMID: 36530167
PMC: 10106982.
DOI: 10.15252/embj.2022111500.
Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors.
Ashraf N, Asari A, Yousaf N, Ahmad M, Ahmed M, Faisal A
Front Chem. 2022; 10:1003816.
PMID: 36405310
PMC: 9666879.
DOI: 10.3389/fchem.2022.1003816.
Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer.
Sarwar S, Morozov V, Purayil H, Daaka Y, Ishov A
Cell Death Dis. 2022; 13(10):868.
PMID: 36229449
PMC: 9561175.
DOI: 10.1038/s41419-022-05312-8.
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma.
Yu J, Gao G, Wei X, Wang Y
BMC Cancer. 2022; 22(1):786.
PMID: 35850753
PMC: 9290216.
DOI: 10.1186/s12885-022-09899-1.
Comprehensive analysis of the prognostic value and immune implications of the TTK gene in lung adenocarcinoma: a meta-analysis and bioinformatics analysis.
Li B, Gu X, Zhang H, Xiong H
Anim Cells Syst (Seoul). 2022; 26(3):108-118.
PMID: 35784389
PMC: 9246214.
DOI: 10.1080/19768354.2022.2079718.
Overcome cancer drug resistance by targeting epigenetic modifications of centrosome.
Jia Z, Wang X, Zhang H
Cancer Drug Resist. 2022; 2(2):210-224.
PMID: 35582716
PMC: 8992632.
DOI: 10.20517/cdr.2018.010.
The chirality of the mitotic spindle provides a mechanical response to forces and depends on microtubule motors and augmin.
Trupinic M, Kokanovic B, Ponjavic I, Barisic I, Segvic S, Ivec A
Curr Biol. 2022; 32(11):2480-2493.e6.
PMID: 35537456
PMC: 9235856.
DOI: 10.1016/j.cub.2022.04.035.
Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.
Guo J, Li W, Cheng L, Gao X
Int J Gen Med. 2022; 15:3933-3941.
PMID: 35431572
PMC: 9012340.
DOI: 10.2147/IJGM.S353708.
Association of High Expression of Mitochondrial Fission Regulator 2 with Poor Survival of Patients with Esophageal Squamous Cell Carcinoma.
Li H, Zhu X, Zhang W, Lu W, Liu C, Ma J
J Cancer Prev. 2022; 26(4):250-257.
PMID: 35047451
PMC: 8749323.
DOI: 10.15430/JCP.2021.26.4.250.